# Appili Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/appili-therapeutics

- Industry: Biotechnology
- Headquarters: Halifax, Canada
- Website: www.appilitherapeutics.com
- Total disclosed funding: $3.3M
- Latest round: Seed (May 25, 2016)
- Investors on record: 3

## About

Appili Therapeutics Inc. is a biopharmaceutical company focused on developing innovative treatments for infectious diseases through advanced therapeutics, addressing critical unmet medical needs worldwide.Founded in 2015 in Halifax, Canada, Appili Therapeutics Inc. develops therapies targeting infectious diseases. The firm has undergone strategic pivots, including a focus on product commercialization via partnerships. The company has raised CAD 7.000 mn across several funding rounds, with their latest round being VENTURE DEBT for CAD 0.300 mn on June 10, 2020. The leadership team includes CEOs Armand Balboni and Donald Cilla.Appili Therapeutics Inc. specializes in developing solutions for unmet medical needs in infectious diseases, with core products including LIKMEZ™ (ATI-1501) for serious infections, ATI-1701, a potential live-attenuated vaccine for tularemia, and ATI-1801, a topical antiparasitic for skin infections. Their customer base comprises healthcare providers and pharmaceutical distributors in North America and Europe, focusing on enhancing treatment efficacy and patient adherence.In 2023, Appili Therapeutics reported a revenue of CAD 958,686.30 with an EBITDA of CAD -805,934.40. Revenue is generated through partnerships and agreements with healthcare institutions and distributors, aligning interests with partners to address infectious disease challenges.Appili Therapeutics plans to expand its product portfolio with ongoing developments, aiming to launch new therapies by the end of 2024. The company targets market expansion in North America and Europe, utilizing funds from their recent CAD 15.52 million private placement in June 2020 to support these initiatives. This funding will help advance their pipeline and enhance market penetration.

## Funding rounds

- Seed, May 25, 2016, $3.3M — Invest Nova Scotia, Atlantic Canada Opportunities Agency, National Research Council of Canada Industrial Research Assistance

## Investors

- Invest Nova Scotia — Seed
- Atlantic Canada Opportunities Agency — Seed
- National Research Council of Canada Industrial Research Assistance — Seed